Cleveland Biolabs, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 07:31 am
Cleveland BioLabs, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 669,237 compared to USD 592,191 a year ago. Net loss was USD 659,506 compared to USD 369,838 a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago. For the half year, operating loss was USD 1.220 million compared to USD 1.036 million a year ago. Net loss was USD 1.197 million compared to USD 958,370 a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.08 a year ago.